Inflammatory Bowel Disease Drugs Market to Surpass USD 27.65 Billion by 2031 Driven by Rising Prevalence of IBD and Robust Pipeline Development
The Inflammatory Bowel Disease (IBD) Drugs Market is projected to reach a valuation of USD 27.65 billion by 2031, experiencing...